Stephen I. Foundling
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
- Biotechnology top 10%
- Enzyme Production and Characterization
Papers in
-
- Biochemical and Structural Characterization 3
- Glycosylation and Glycoproteins Research 2
- Oncology 6
- Peptidase Inhibition and Analysis 6
- Co-authors
- Michel Monod (5 shared papers)Ben M. Dunn (2 shared papers)Martin Fusek (3 shared papers)Jeffrey A. Loy (1 shared paper)Gerald Koelsch (2 shared papers)Jordan Tang (2 shared papers)Xinli Lin (2 shared papers)Kenneth W. Jackson (1 shared paper)
- Journals
- Advances in experimental medicine and biology (3 papers)Biochemistry (3 papers)FEBS Letters (2 papers)Microbiology (1 paper)Biochemical Society Transactions (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Stephen I. Foundling
15 papers receiving 459 citations
Peers
Comparison fields: 5 of 69
- Infectious Diseases 194
- Biotechnology 68
- Virology 34
- Oncology 128
- Molecular Biology 243
Countries citing papers authored by Stephen I. Foundling
This map shows the geographic impact of Stephen I. Foundling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen I. Foundling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen I. Foundling more than expected).
Fields of papers citing papers by Stephen I. Foundling
This network shows the impact of papers produced by Stephen I. Foundling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen I. Foundling. The network helps show where Stephen I. Foundling may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen I. Foundling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 76 | |
| 2 | 1992 | 60 | |
| 3 | 1996 | 60 | |
| 4 | 1987 | 57 | |
| 5 | 1996 | 42 | |
| 6 | 1994 | 41 | |
| 7 | 1997 | 28 | |
| 8 | 1993 | 24 | |
| 9 | 1996 | 17 | |
| 10 | 1999 | 16 | |
| 11 | 1988 | 14 | |
| 12 | 1998 | 13 | |
| 13 | 1985 | 13 | |
| 14 | 1998 | 3 | |
| 15 | 1995 | 1 |
About Stephen I. Foundling
Stephen I. Foundling is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Biotechnology and Materials Chemistry, having authored 15 papers that have together received 465 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Enzyme Structure and Function (4 papers), Antifungal resistance and susceptibility (4 papers), Enzyme Production and Characterization (4 papers), Biochemical and Structural Characterization (3 papers), Probiotics and Fermented Foods (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Metalloenzymes and iron-sulfur proteins (1 paper). The work is most often cited by research in Infectious Diseases (194 citations), Biotechnology (68 citations), Virology (34 citations), Oncology (128 citations) and Molecular Biology (243 citations). Stephen I. Foundling has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Michel Monod, Ben M. Dunn, Martin Fusek, Jeffrey A. Loy, Gerald Koelsch, Jordan Tang, Xinli Lin, Kenneth W. Jackson, John Kay and Martin J. Valler. Their work appears in journals such as Advances in experimental medicine and biology, Biochemistry, FEBS Letters, Microbiology and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.